s/
Stockslash
⌘K
Stocks
ELV
Not investment advice · 13F data lagged ~45 days · Full disclaimer
EL

Elevance Health

ELV13F as of Jun 30, 2026 · next update ~Nov 14
Who's buying ELV

Top funds were split on Elevance Health in Q2 (Apr⁠–⁠Jun)

Buying:
Funds6InsidersCongress
11 funds$5.1B held3.2% avg. weightQ2: 6 bought / 4 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 14 filings
Net buying$14.98M
DateInsiderTypeSharesPriceValue
Oct 22, 2026
Mark Kaye
VP & CFO
Sold10,584$440.13$4.66M
Jul 17, 2026
Ramiro G Peru
Director
Bought1,000$366.05$366K
Jul 17, 2026
Gail Boudreaux
President & CEO
Bought2,725$367.79$1.00M
Jun 12, 2026
Ronald W Penczek
CAO & Controller
Sold369$403.16$149K
Jun 11, 2026
Robert L Dixon Jr.
Director
Sold151$401.77$61K
May 19, 2026
Ronald W Penczek
CAO & Controller
Sold1,531$403.13$617K
Mar 12, 2026
Amy W Schulman
Director
Sold26$287.50$7K
Mar 6, 2026
Charles Morgan Kendrick Jr.
VP & President
Sold3,196$284.92$911K
Mar 5, 2026
Steven H Collis
Director
Bought3,000$289.84$870K
Aug 19, 2025
Susan D. Devore
Director
Bought1,200$312.15$375K
Jul 18, 2025
Gail Boudreaux
President & CEO
Bought8,500$286.94$2.44M
Apr 24, 2025
Mark Kaye
VP & CFO
Sold4,588$424.82$1.95M
Mar 10, 2025
Ronald W Penczek
CAO & Controller
Sold443$415.13$184K
Mar 5, 2025
Charles Morgan Kendrick Jr.
VP & President
Sold3,504$396.30$1.39M